AstraZeneca sees big healthcare changes under Trump

LONDON (Reuters) - Drugmaker AstraZeneca expects major U.S. healthcare changes after Donald Trump's election victory but its chief executive warned on Thursday that pricing pressures in the world's biggest drugs market would not go away.

AstraZeneca sees big healthcare changes under Trump
Read More


Bagikan Berita Ini